FundingWatcher
Home / Startups / Top biotech startups / Biotech startups that raised Series B / Biotech startups that raised Series B in Germany

Biotech startups that raised Series B in Germany

Updated 16 Nov 2026

Reset
Biotech startups that raised Series B in Germany
One-time CSV
  • 35 funded companies, 20 with a website
  • Last round, amount, date, total raised and investors
  • CRM-ready CSV, 18 columns
  • Download right after payment
With founder contacts
Compiled to order
  • The full startup CSV, plus founders and executives
  • Up to 2 founders or CEOs per company, compiled to order
  • Name, job title and LinkedIn URL where found
  • Verified direct email per person
  • Startup CSV at once, contacts CSV by mail within 24 hours
Download right after paymentFree 10-row sampleSecure checkout by Stripe

Not sure about the data?

Download a free 10-row sample first. No account, no payment.

startups-biotech--series-b~germany.csv35 rows × 18 columns
CompanyCityLast roundAmountDate
ComputomicsTübingenSeries B$7.3M2026-08-18
NVision Quantum TechnologiesUlmSeries B$38.0M2026-05-13
OrbemMunichSeries B$64.6M2026-01-20
ExcivaHeidelbergSeries B$59.4M2026-01-20
ClinomicAachenSeries B$25.3M2025-04-08
QualifyzeFrankfurtSeries B$54.0M2024-09-10
Bind-XPlaneggSeries B$11.0M2023-08-01
Resolve BioSciencesDüsseldorfSeries B$71.0M2022-10-24

8 rows of the CSV in 5 of its 18 columns.

35
Startups
$617.8M
Total raised
5
Funded in the last 12 months
$219.4M
Raised in the last 12 months

Source: FundingWatcher. Data as of 16 November 2026. "Last 12 months" is the 365 days to that date.

Newest rounds

11 of 35
11 rows
Company What they do Sector City Last round Amount Date Total raised Investors Employees Founded
Computomics Computomics applies artificial intelligence to genomics data to advance agricultural solutions. Artificial intelligence Tübingen Series B $7.3M 2026-08-18 $10.0M HTGF (High-Tech Gruenderfonds), VentureOut, European Innovation Council +2 11 to 50 2012
NVision Quantum Technologies NVision Quantum Technologies develops quantum-based imaging technology that enhances standard MRI systems. Biotech Ulm Series B $38.0M 2026-05-13 $155.2M Entrée Capital, European Commission, Playground Global +2 101 to 250 2015
Orbem Orbem provides AI-powered imaging and analytics for non-invasive biological insights. Artificial intelligence Munich Series B $64.6M 2026-01-20 $106.5M European Innovation Council, Possible Ventures, 83North +1 101 to 250 2019
Exciva Exciva develops clinical-stage biopharmaceutical therapies for neuropsychiatric symptoms of dementia. Biotech Heidelberg Series B $59.4M 2026-01-20 $69.8M Andera Partners, LBBW VC, Cure8 Ventures 1 to 10 2015
Clinomic Clinomic is a medical AI company focused on critical care. Artificial intelligence Aachen Series B $25.3M 2025-04-08 $54.6M German Federal Ministry of Research, Technology and Space 51 to 100 2019
Qualifyze Qualifyze provides global quality audit and site risk management solutions for life sciences companies. Biotech Frankfurt Series B $54.0M 2024-09-10 Insight Partners, APX, HV Capital +2 101 to 250 2019
Resolve BioSciences Resolve BioSciences conducts biotechnology research in molecular cartography. Biotech Düsseldorf Series B $71.0M 2022-10-24 $95.0M HTGF (High-Tech Gruenderfonds), EDBI, NRW.BANK +2 51 to 100 2020
Cardior Pharmaceuticals Cardior Pharmaceuticals develops medicines and therapies to treat and prevent heart disease. Biotech Hanover Series B $75.3M 2021-08-25 HTGF (High-Tech Gruenderfonds), EQT Life Sciences, Bristol-Myers Squibb +2 11 to 50 2016
Topas Therapeutics Topas Therapeutics is a biotechnology company developing products for major unmet medical needs. Biotech Hamburg Series B $21.4M 2021-07-29 Boehringer Ingelheim Venture Fund, BioMedPartners, Vesalius Biocapital Partners +1 51 to 100 2006
Hemovent Hemovent is an emerging medical device company developing new technology. Biotech Aachen Series B $5.2M 2019-02-14 $13.5M KfW, NRW.BANK, TechVision Fund +2 1 to 10 2013
Subitec Subitec produces microalgae biomass substances for the cosmetics and food additives industries. Biotech Stuttgart Series B $5.5M 2012-07-16 HTGF (High-Tech Gruenderfonds), KfW, eCAPITAL ENTREPRENEURIAL PARTNERS +1 11 to 50 2000

Table 1. Biotech startups that raised Series B in Germany: the 11 newest rounds whose row carries a description, a city, a named fund and an amount. Source: FundingWatcher. Data as of 16 November 2026. Base: 35.

Largest rounds

Last 12 months
# Company What they do Sector City Last round Amount Date Total raised Investors Employees Founded
1 Orbem Orbem provides AI-powered imaging and analytics for non-invasive biological insights. Artificial intelligence Munich Series B $64.6M 2026-01-20 $106.5M European Innovation Council, Possible Ventures, 83North +1 101 to 250 2019
2 Exciva Exciva develops clinical-stage biopharmaceutical therapies for neuropsychiatric symptoms of dementia. Biotech Heidelberg Series B $59.4M 2026-01-20 $69.8M Andera Partners, LBBW VC, Cure8 Ventures 1 to 10 2015
3 NVision Quantum Technologies NVision Quantum Technologies develops quantum-based imaging technology that enhances standard MRI systems. Biotech Ulm Series B $38.0M 2026-05-13 $155.2M Entrée Capital, European Commission, Playground Global +2 101 to 250 2015
4 Computomics Computomics applies artificial intelligence to genomics data to advance agricultural solutions. Artificial intelligence Tübingen Series B $7.3M 2026-08-18 $10.0M HTGF (High-Tech Gruenderfonds), VentureOut, European Innovation Council +2 11 to 50 2012

Table 2. Biotech startups that raised Series B in Germany: the 4 largest rounds of the last 12 months. Source: FundingWatcher. Data as of 16 November 2026.

Most active investors

By companies backed
#InvestorTypeLocation CompaniesShare Funded, 12 monthsLatest
1 HTGF (High-Tech Gruenderfonds) Venture capital firm Bonn, Germany 13 37% 1 Computomics
2 NRW.BANK Government investment office Düsseldorf, Germany 4 11%
3 German Federal Ministry of Research, Technology and Space Government investment office Bonn, Germany 3 9% 1 NVision Quantum Technologies
4 Andera Partners Private equity firm Paris, France 3 9% 1 Exciva
5 KfW Government investment office Frankfurt, Germany 3 9%
6 European Innovation Council Startup accelerator Brussels, Belgium 2 6% 2 Computomics, Orbem
7 BASF Venture Capital Corporate venture arm Ludwigshafen, Germany 2 6% 1 Computomics
8 Boehringer Ingelheim Venture Fund Corporate venture arm Ingelheim Am Rhein, Germany 2 6%
9 EQT Life Sciences Private equity firm Amsterdam, The Netherlands 2 6%
10 MIG Capital Venture capital firm Munich, Germany 2 6%
11 Bayern Kapital Venture capital firm Landshut, Germany 2 6%
12 eCAPITAL ENTREPRENEURIAL PARTNERS Venture capital firm Münster, Germany 2 6%
13 Forbion Capital Partners Private equity firm Naarden, The Netherlands 2 6%
14 Zukunftsfonds Heilbronn Venture capital firm Heilbronn, Germany 2 6%
15 MBG Baden Wuerttemberg Venture capital firm Stuttgart, Germany 1 3% 1 Computomics

Table 3. Biotech startups that raised Series B in Germany: the funds recorded as investors in the most companies. Latest: companies they back that raised in the last 12 months. Source: FundingWatcher. Data as of 16 November 2026.

Sectors

SectorsCompaniesShareTotal raised
Health care 22 63% $501.3M
Software 5 14% $171.2M
Artificial intelligence 3 9% $171.2M
Hardware 1 3% $106.5M

Table 4. Biotech startups that raised Series B in Germany by sector. Source: FundingWatcher. Data as of 16 November 2026.

Funding stage

Funding stageCompaniesShareMedian last round
Series B 35 100% $15.3M

Table 5. Biotech startups that raised Series B in Germany by stage of the most recent round. Source: FundingWatcher. Data as of 16 November 2026.

Cities

CitiesCompaniesShare
Munich 5 14%
Heidelberg 2 6%
Aachen 2 6%
Martinsried 2 6%
Berlin 2 6%
Bielefeld 2 6%
Tübingen 1 3%
Ulm 1 3%
Frankfurt 1 3%
Planegg 1 3%
Düsseldorf 1 3%
Duisburg 1 3%

Table 6. Biotech startups that raised Series B in Germany by headquarters city. Source: FundingWatcher. Data as of 16 November 2026.

Rounds by month

Rounds by monthCompaniesShareRaised
August 2026 1 20% $7.3M
June 2026 1 20% $50.0M
May 2026 1 20% $38.0M
January 2026 2 40% $124.1M

Table 7. Biotech startups that raised Series B in Germany: most recent round by month, last 12 months. Source: FundingWatcher. Data as of 16 November 2026.

Most recent round by year

Most recent round by yearCompaniesShareRaised
2026 5 14% $219.4M
2025 1 3% $25.3M
2024 1 3% $54.0M
2023 1 3% $11.0M
2022 3 9% $86.3M
2021 6 17% $285.7M

Table 8. Biotech startups that raised Series B in Germany by year of the most recent round. Source: FundingWatcher. Data as of 16 November 2026.

Founding year

Founding yearCompaniesShare
2020 to 2022 1 3%
2015 to 2019 12 34%
2010 to 2014 9 26%
Before 2010 13 37%

Table 9. Biotech startups that raised Series B in Germany by founding year. Source: FundingWatcher. Data as of 16 November 2026.

Team size

Team sizeCompaniesShare
1 to 10 7 20%
11 to 50 14 40%
51 to 100 8 23%
101 to 250 5 14%
10,001 or more 1 3%

Table 10. Biotech startups that raised Series B in Germany by headcount. Source: FundingWatcher. Data as of 16 November 2026.

Method

Sources, fields and exclusions of both files: Method.

Questions

How many biotech startups in Germany whose last round is Series B are on the list?
35, in the file dated 16 November 2026. 5 of them closed their most recent round in the last 12 months.
What does the CSV contain?
One row per company, 18 columns: name, domain, website, linkedin, description, founded, employees, city, region, country, sectors, funding_stage, last_round, last_round_date, last_round_usd, total_raised_usd, rounds, investors.
How much does the list cost?
$29 one-time for all 35 rows, no account. Every investor and every startup, two files, cost $99. With founder contacts, up to 2 founders or CEOs per company compiled to order and mailed within 24 hours, $199.
What arrives after payment?
At once: the CSV download link, on the page after payment and by mail.
Can I see rows before buying?
The 3 rows under the buy button are rows of the CSV with every column. The form below it mails 10 rows.
How current is the data?
The file is dated 16 November 2026. The download link serves the current file each time it is opened.

Biotech startups that raised Series B in Germany: 35 rows, CSV, $29 one-time.

At once: the CSV download link, on the page after payment and by mail.

Columns: name, domain, website, linkedin, description, founded, employees, city, region, country, sectors, funding_stage, last_round, last_round_date, last_round_usd, total_raised_usd, rounds, investors.

With founder contacts: $199 one-time. List CSV right after payment; up to 2 verified founder or CEO emails per company compiled to order within 24 hours.

Not sure about the data?

Download a free 10-row sample first. No account, no payment.

Biotech at other stages in Germany

Other sectors that raised Series B in Germany

Cite: FundingWatcher, 35 biotech companies in Germany whose most recent round is Series B, 16 November 2026. https://fundingwatcher.com/startups/biotech/series-b/germany/